Cargando…
Reviewing the journey to the clinical application of bacteriophages to treat multi-drug-resistant bacteria
Antimicrobial resistance (AMR) was a leading cause of death globally in 2019. Sadly, COVID-19 has exacerbated AMR, nonetheless, the process of developing new antibiotics remains very challenging. This urgently requires the adoption of alternative approaches to treat multi-drug-resistant bacterial in...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548642/ https://www.ncbi.nlm.nih.gov/pubmed/37789281 http://dx.doi.org/10.1186/s12879-023-08621-1 |